123 related articles for article (PubMed ID: 16222171)
21. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
[TBL] [Abstract][Full Text] [Related]
22. Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation.
Gordeuk VR; Lovato L; Barton J; Vitolins M; McLaren G; Acton R; McLaren C; Harris E; Speechley M; Eckfeldt JH; Diaz S; Sholinsky P; Adams P
Can J Gastroenterol; 2012 Jun; 26(6):345-9. PubMed ID: 22720276
[TBL] [Abstract][Full Text] [Related]
23. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
[TBL] [Abstract][Full Text] [Related]
24. Population screening for hemochromatosis: a study in 5370 Spanish blood donors.
Sánchez M; Villa M; Ingelmo M; Sanz C; Bruguera M; Ascaso C; Oliva R
J Hepatol; 2003 Jun; 38(6):745-50. PubMed ID: 12763366
[TBL] [Abstract][Full Text] [Related]
25. Blood donors with hereditary hemochromatosis.
Røsvik AS; Ulvik RJ; Wentzel-Larsen T; Hervig T
Transfusion; 2010 Aug; 50(8):1787-93. PubMed ID: 20345568
[TBL] [Abstract][Full Text] [Related]
26. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
27. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
Gurrin LC; Bertalli NA; Dalton GW; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Nicoll AJ; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
Hepatology; 2009 Jul; 50(1):94-101. PubMed ID: 19554541
[TBL] [Abstract][Full Text] [Related]
28. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
29. Differential HFE allele expression in hemochromatosis heterozygotes.
Rosmorduc O; Poupon R; Nion I; Wendum D; Feder J; Béréziat G; Hermelin B
Gastroenterology; 2000 Oct; 119(4):1075-86. PubMed ID: 11040194
[TBL] [Abstract][Full Text] [Related]
30. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
31. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
32. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women.
Rossi E; Olynyk JK; Cullen DJ; Papadopoulos G; Bulsara M; Summerville L; Powell LW
Clin Chem; 2000 Feb; 46(2):162-6. PubMed ID: 10657371
[TBL] [Abstract][Full Text] [Related]
33. A primer for predicting risk of disease in HFE-linked hemochromatosis.
Adams PC; Walker AP; Acton RT
Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576
[TBL] [Abstract][Full Text] [Related]
34. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
[TBL] [Abstract][Full Text] [Related]
35. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
[TBL] [Abstract][Full Text] [Related]
36. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
37. Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry.
Beutler E; Felitti V; Gelbart T; Waalen J
Br J Haematol; 2003 Mar; 120(5):887-93. PubMed ID: 12614226
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.
Kucinskas L; Juzenas S; Sventoraityte J; Cedaviciute R; Vitkauskiene A; Kalibatas V; Kondrackiene J; Kupcinskas L
Ann Hematol; 2012 Apr; 91(4):491-5. PubMed ID: 21947086
[TBL] [Abstract][Full Text] [Related]
39. HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients.
Saliou P; Le Gac G; Mérour MC; Tripogney C; Chanu B; Gourlaouen I; Nousbaum JB; Férec C; Scotet V
Ann Hematol; 2015 Jul; 94(7):1225-7. PubMed ID: 25740382
[No Abstract] [Full Text] [Related]
40. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
